PTGS1 and Alzheimer disease: Upregulation of COX-1 leads to increased production of PGs including prostaglandin E2 (PGE2), which exacerbates Aβ aggregation, synaptic degeneration, neuronal apoptosis, and cognitive decline in AD models [17].